The Price of Understaffing: What UK Healthcare Outcomes Really Tell Us
From workforce gaps and wage suppression to avoidable deaths, delayed cancer diagnoses, record waiting lists and a £60 billion negligence liability — a data-driven examination of consequence.
This is the third post in a three-part series. If you haven’t read the first two, the argument builds on their foundations:
Part 1 → UK healthcare staff: fewer in number and lower paid than comparable countries
Part 2 → Where does the NHS spend the £60bn it saves on staffing? Non-staff costs examined
In the first two posts in this series we established two uncomfortable truths. First, the UK has significantly fewer doctors and nurses per capita than comparable high-income nations, and pays them less. Second, the money not spent on staff doesn’t disappear — it ends up absorbed by non-staff costs: pharmaceuticals, management consultancies, PFI financing, administration, and IT procurement at a premium. The staffing gap between the NHS and comparable Scandinavian systems is up to £60 billion per year.
In this third post we ask the most important question of all: what does that gap cost patients?
We examine five major outcome domains — avoidable mortality, clinical outcomes for cancer, heart attack and stroke, elective surgery waiting times, clinical negligence costs, and temporary staffing expenditure — and look at what the operational data (not trial data) tells us about statistical correlation with staffing levels.
1. Avoidable Mortality: Deaths the System Should Have Prevented
Avoidable mortality is split into two components. Preventable mortality reflects failures of public health upstream. Treatable mortality — deaths that should not have occurred with timely, effective clinical intervention — is the sharpest and most relevant mirror for health system performance, because it isolates what healthcare itself can and should prevent.
The Nuffield Trust’s analysis of OECD data shows that the UK’s treatable mortality rate was 71 per 100,000 population in 2019 — above that of seven Western European comparator countries for which data was available that year. In this measure, a higher number means more deaths — more people whose lives the healthcare system should have saved but did not.
| Country | Treatable deaths / 100,000 | Year | vs UK |
|---|---|---|---|
| Switzerland | ~39 | 2021 | Better (−45%) |
| Australia | 49 | 2022 | Better (−31%) |
| Nordic countries (Sweden, Norway, Denmark) | Below UK | 2021–22 | Consistently better — lowest-mortality quartile across OECD |
| 4 further W. European nations | Below UK | 2019 | All outperform UK (Nuffield Trust / OECD) |
| UK | 71 | 2019 | Above 7 of its Western European peers |
| OECD average | 79 | 2021 | UK below average only because E. European countries raise it |
| United States | 95 | 2022 | Worst among comparable high-income nations |
| Sources: Nuffield Trust/OECD (2024); OECD Health Statistics. Age-standardised, deaths under 75. Higher = worse. | |||
The UK at 71 sits below the OECD average of 79 only because that average is pulled upward by Eastern and Southern European countries with significantly weaker healthcare systems. Against its genuine peer group — France, Germany, the Netherlands, Belgium, Switzerland, Australia, and the Nordic nations — the UK performs poorly. The difference is in healthcare capacity and staffing levels.
A peer-reviewed cross-national panel study using OECD data across 26 countries found that a 1% increase in nurse-staffing density reduces 30-day mortality from heart attack by 0.65%, from haemorrhagic stroke by 0.60%, and from ischaemic stroke by 0.80%. Sweden and Denmark had the highest simulated reductions in overall HCQI mortality from their nursing levels (−3.53 and −3.31 respectively).
Source: Labbé et al. (2018) — 26 OECD countries, 2005–2015.
2. Cancer Care: Survival Rates That Lag Behind Our Neighbours
The most recent EUROCARE-6 data analysed across 29 European countries reveals a consistent pattern: Nordic countries dominate the top of survival tables across most major cancers, while the UK is near or below average for its income group.
| Cancer Type | Sweden | Norway | Denmark | UK | EU-24 Avg. |
|---|---|---|---|---|---|
| Ovarian (5-yr) | 46.5% | 45%+ | – | 36.2% | 39.2% |
| Lung (5-yr) | 19.5% | 19.0% | – | 13.3% | ~15–16% |
| Melanoma (5-yr) | 87%+ | 87%+ | 87%+ | ~83% | 83% |
| Pancreatic (5-yr) | ~10–12% | ~10–12% | ~10–12% | 6.8% | ~9% |
| Sources: EUROCARE-6 (De Angelis et al., 2024); EU Country Cancer Profiles Synthesis Report 2025 (OECD/EU). Five-year relative survival rates. | |||||
For ovarian cancer, Sweden records 46.5% five-year survival compared to the UK’s 36.2% — a gap of over ten percentage points that directly translates to lives lost. For lung cancer the UK at 13.3% is significantly below Sweden (19.5%) and Norway (19.0%).
“Survival was persistently higher in Australia, Canada, and Sweden, intermediate in Norway, and lower in Denmark, England, Northern Ireland and Wales, particularly in the first year after diagnosis and for patients aged 65 and older.” — International Cancer Benchmarking Partnership, Lancet, 2011
3. Heart Attack and Stroke: Where Every Minute — and Every Nurse — Counts
A landmark study using nationwide registry data — 87 Swedish hospitals (119,786 patients) and 242 UK hospitals (391,077 patients), 2004–2010 — found that 30-day mortality from AMI was lower in Swedish hospitals (8.4%) than UK hospitals (9.7%).
|
Sweden — AMI
8.4%
30-day case-mix adjusted mortality
|
UK — AMI
9.7%
30-day case-mix adjusted mortality — and higher variation between hospitals
|
That 1.3 percentage point difference translates to thousands of preventable deaths annually across 100,000+ AMI admissions per year.
At the ward level in the English NHS, a retrospective longitudinal study of 66,923 admissions found a statistically significant association between registered nurse fill-rate and in-hospital mortality (OR 0.9883, 95% CI 0.9773–0.9996, p=0.0416). An extra 12-hour shift by an RN was associated with a 9.6% reduction in the odds of a patient death.
Critically, there was no statistically significant association for healthcare support workers or agency nurses — meaning agency staff are not effective substitutes for permanent, ward-familiar RNs.
Source: Propper et al., BMJ Quality & Safety 2023; Dall’Ora et al., JAMA Network Open 2024.
4. Elective Surgery Waiting Times: A Crisis Within a Crisis
As of late 2025, 7.3 million elective procedures were on the NHS waiting list in England. Only 62% of patients were waiting less than 18 weeks — far below the 92% constitutional standard. For orthopaedic procedures:
|
NHS — Hip Replacement
24–28 wks
Average wait 2025 (pre-pandemic: 12–13 weeks)
|
NHS — Knee Replacement
28–29 wks
Average wait 2025 (pre-pandemic: ~13 weeks)
|
|
Spain, Finland, Italy
~Pre-covid
Hip/knee wait recovery broadly on track by 2023
|
UK vs Peers
50% longer
England’s median hip wait still 50% longer than pre-2020
|
“England has fewer hospital beds, lower numbers of key staff and lower levels of investment in buildings and equipment than many other high-income countries — and this is likely to have affected how quickly the millions of people waiting can have the surgery they need to live comfortably.” — Nuffield Trust, 2024 analysis of OECD Health Statistics
Countries with more staff, more beds, and better-paid permanent workforces recovered more quickly because they had more capacity to absorb the backlog. England entered the pandemic with structural vulnerabilities — the same ones documented in Parts 1 and 2 of this series — and those vulnerabilities have defined the pace of recovery.
5. Clinical Negligence: The Hidden Fiscal Iceberg
| Metric | Figure | Trend |
|---|---|---|
| Annual claims paid (2024/25) | £3.1 billion | +10% year-on-year |
| Annual claims paid (2023/24) | £2.8 billion | +6.8% on prior year |
| Annual claims paid (2006/07, real terms) | £1.1 billion | Baseline — 182% real-terms increase since |
| “Cost of harm” estimate (CNST, 2024/25) | £4.6 billion | Wider measure |
| Total provision for future liabilities (March 2025) | ~£60.0 billion | 2nd largest government balance sheet liability |
| Maternity-related liabilities (since 2019) | £27.4 billion | 52% of annual pay-outs relate to obstetrics |
| New claims filed (2024/25) | 14,428 | +5% — exceeds pre-pandemic peak |
⚠️ KEY FINDING: The £60 billion total negligence liability is not primarily a legal or administrative failure. It is a patient safety failure. Patient safety failures are systematically linked in the operational literature to inadequate staffing, high use of temporary staff, and overworked permanent staff — precisely the conditions documented in Part 1 of this series.
6. Agency and Temporary Staff Spend: The Vicious Cycle
The NHS’s reliance on agency staffing is the most direct and visible financial consequence of the workforce shortages described in Part 1. The cycle is self-reinforcing and extremely expensive.
7. The Statistical Case: Connecting Staffing Inputs to Outcome Outputs
The six outcome domains above are connected through a common mechanism: the ratio of appropriately trained, well-supported, permanent clinical staff to patients in need. The operational evidence base for this relationship is extensive and consistent in direction.
Key operational evidence points (all statistically significant):
| OECD: Nurse staffing → AMI/Stroke mortality | 1% increase in nurse density → 0.65% reduction in AMI 30-day mortality; 0.80% reduction in ischaemic stroke mortality. Analysis of 26 OECD countries 2005–2015. |
|---|---|
| NHS England: RN fill-rate → inpatient mortality | Extra 12-hour RN shift: 9.6% reduction in odds of patient death (OR 0.9044; p=0.0416). No equivalent effect for healthcare support workers or agency nurses. Study of 66,923 admissions, 53 wards, 2017. |
| Multidisciplinary staffing → hospital mortality | Hospitals with lower medical and AHP staff had 4% higher mortality rates (RR 1.04; 95% CI 1.02–1.06). Pooled finding from a systematic review (Dall’Ora et al., 2023). |
| Temporary staffing → mortality risk not fully mitigated | 626,313 patient admissions (JAMA Network Open, 2024): days of low nurse staffing, even when remedied by temporary staff, carried elevated mortality risk compared to adequate permanent staffing. |
| Nuffield Trust: Structural vulnerabilities → slow elective recovery | Across 10 high-income nations, England’s post-pandemic recovery for hip/knee replacements was slower than Spain, Finland, Italy, Portugal, Sweden, and Norway. “Fewer beds, lower numbers of key staff” explicitly named as causal factors. |
| NHS RN seniority → mortality reduction (dose-response) | A senior RN (Band 7–8) had 2.2 times the mortality-reducing impact of a Band 5 RN. Pay suppression drives experienced staff out; junior replacements are not equivalent. |
8. Operational Productivity: Theatre Utilisation, Cases Per List, and the Staffing Paradox
Theatre Utilisation: 38% of Lists Underused Before the Pandemic
An NHS Improvement audit in 2019 found that 38% of theatre lists were underutilised, with unused theatre time estimated to cost the NHS approximately £400 million annually. NHS England’s 2024/25 operational planning guidance set a target of making “significant improvement towards” 85% theatre utilisation — not that the target was being met.
🏥 A note on the metric: The NHS’s “capped theatre utilisation” (CTU) measure in the Model Hospital database is calculated in a mathematically invalid way (Pandit et al., British Journal of Anaesthesia, 2023). The underutilisation problem is real, but the 85% target should be treated as directionally correct rather than a precise comparable benchmark.
Cases Per List: Team Stability Is the Statistically Proven Driver
A study of 255,757 procedures across 38 UK hospitals found that switching between different procedure types on a list increased operative duration by an average of 6.48%. A systematic review of 76 studies concluded that employing specialised and stable teams in dedicated operating rooms showed significant improvements in outcomes; disturbances and communication failures negatively affected operative time and surgical safety.
A case-control study of cataract surgery found an odds ratio of 1.7 (95% CI 1.0–3.1) for complications on lists affected by unplanned staff absence — the direct consequence of thin staffing pools with no experienced cover.
The Waiting List Paradox: More Staff, Barely Any Reduction
|
NHS Staff Growth 2019–2024
+20%
FTE workforce increase
|
Waiting List Change
+73%
Mar 2020 → Mar 2024 (4.4m → 7.5m)
|
|
Elective Recovery Target
20.9%
Activity increase vs 2019/20 set for 2024/25 — significantly missed
|
Actual YoY Gain 2024/25
2.7%
Year-on-year acute productivity growth (NHS England)
|
Important context: The 2.7% year-on-year rise in 2024/25 is one year’s growth. It does not conflict with NHS England’s position that level productivity remained approximately 8% below 2019/20 — a critical stock-versus-flow distinction often muddled in political debate.
Trust leaders surveyed by NHS Providers (May 2024) identified the top barriers to productivity as: delayed discharges (48%), lack of revenue funding (38%), and patient acuity (37%). The two initiatives most cited as improving productivity: reducing agency spend (55%) and workforce retention initiatives (53%). Not technology. Not management restructuring. Both top levers were about stabilising the permanent workforce.
| Productivity Driver | Mechanism | Staffing Link |
|---|---|---|
| Theatre underutilisation (38% of lists, £400m/yr) | Beds unavailable; staff absent; lists cancelled | Direct |
| Switching procedures on list (+6.48% time/case) | Fragmented scheduling; no dedicated specialist lists | Direct |
| Unplanned staff absence → complications (OR 1.7) | Thin staffing pools; no resilience | Direct |
| +20% staff, waiting list barely reduced | Younger/less experienced workforce; churn; burnout | Direct — consequence of pay suppression |
| Delayed discharge blocking beds → cancelled lists | Social care cannot absorb medically fit patients | Indirect — social care staffing crisis |
| Staff burnout and sickness absence (+18% vs pre-pandemic) | Reduced capacity, unplanned leave, reduced effort | Direct — pay dissatisfaction and overwork |
9. The Causal Chain: How Pay, Staffing, and Staff Effectiveness Connect to Every Outcome
The eight preceding sections share a single causal root. The chain runs in four documented steps: inadequate pay → attrition and vacancies → depleted, less experienced, less effective workforce → worse clinical outcomes across every domain measured.
Link 1: Pay → Dissatisfaction → Intent to Leave
A 2025 cohort study in The Lancet Regional Health — Europe (UK-REACH cohort) found that pay dissatisfaction is strongly associated with attrition intentions across all staff groups. NHS Employers’ analysis shows a Band 7 ward manager suffered a 13.6% real-terms pay decline between 2013 and 2023. Junior doctor pay satisfaction collapsed from 46% in 2020 to 13.6% in 2023.
“An investment in NHS pay, by reducing attrition and staff shortages and supporting service reform, should lead to improved public health outcomes, labour market participation, and higher national income.”
NHS Pay Review Body, 36th Report 2023. HMSO Cm 866. — the statutory advisory body to government on NHS remuneration.
Link 2: Dissatisfaction and Attrition → Vacancies → Agency Dependency
In 2022, a record 170,000 NHS workers left hospital and community health services, including 41,000 nurses. By September 2023 there were 121,070 recorded vacancies including 42,300 nursing vacancies. These vacancies are filled by agency staff at a peak annual cost of £3.5 billion, or by internationally recruited nurses with no institutional knowledge of NHS systems.
|
Staff leavers (2022)
170,000
Record high; including 41,000 nurses
|
NHS Vacancies (Sept 2023)
121,070
Including 42,300 nursing and 8,850 doctor vacancies
|
|
Leavers for health reasons
×4
Nearly quadrupled in a decade
|
Agency spend peak
£3.5bn
2022/23 — financial cost of vacancy-driven attrition
|
Link 3: Depleted Experienced Workforce → Reduced Clinical Effectiveness
A statistically significant mortality benefit was found only for permanently employed registered nurses — not for healthcare support workers, and not for agency nurses. A senior Band 7–8 RN had 2.2 times the mortality-reducing impact of a Band 5 entry-level RN. Every experienced nurse driven out by inadequate pay and replaced by an agency worker represents a net reduction in the safety of every patient on that ward.
NHS staff sickness absence is 18% higher than pre-pandemic levels, with over a quarter of days lost attributable to anxiety, stress, and mental health — the direct product of overwork, understaffing, and persistent pay suppression.
Link 4: Reduced Effectiveness → Every Outcome Measured
| OECD cross-national (26 countries) | 1% increase in nurse staffing density → 0.65% reduction in AMI mortality; 0.80% reduction in ischaemic stroke mortality. Sweden and Denmark show the highest system-level benefits. |
|---|---|
| Cancer outcomes (EUROCARE-6) | Sweden records 46.5% five-year ovarian cancer survival. UK: 36.2%. Lung cancer: Sweden 19.5%, UK 13.3%. Persistent, 30-year gap consistent with structural staffing differences. |
| AMI 30-day mortality (Sweden vs UK) | Sweden 8.4% vs UK 9.7% — registry data from 391,077 UK and 119,786 Swedish patients, 2004–2010. |
The Chain, Summarised
This chain is not a hypothesis. Each link is supported by operational data. The NHS Pay Review Body — the statutory body advising government on NHS remuneration — has itself concluded that investment in pay would produce improved patient outcomes. The only question remaining is whether policymakers choose to act on the evidence they already have.
10. The False Economy: What the NHS Actually Spends on the Consequences
| Cost Category | Annual Figure | Causal Link to Staffing Deficit |
|---|---|---|
| Clinical negligence pay-outs (2024/25) | £3.1bn | Strong — patient safety failures linked to staffing levels |
| Agency staff spend (2024/25) | £2.07bn | Direct — agencies fill gaps from pay-driven vacancies |
| Bank staffing (NHS flexible workers) | ~£2–3bn est. | Direct — same structural cause as agency spend |
| Projected negligence pay-outs (by 2029/30) | >£4bn p.a. | Trajectory continues without structural reform |
| Total negligence liability (balance sheet, March 2025) | ~£60bn | Accumulated years of system failure — largely avoidable harm |
The annual consequence cost — agency spend plus negligence pay-outs — is already running at over £5 billion per year. The entire NHS nursing pay bill could be increased by 10% for approximately £2–3 billion per year — less than the agency spend and negligence claims combined. The NHS is spending more on the consequences of understaffing than it would cost to significantly improve permanent staffing levels.
Conclusion: A False Economy With a Human Cost
This three-part series has told a coherent and uncomfortable story. Part 1 showed the UK trains, employs and pays fewer healthcare staff than comparable nations. Part 2 showed the money not spent on staff has been absorbed by non-staff costs, with a combined premium over Scandinavian systems of up to £60 billion per year.
Part 3 shows what happens downstream. Treatable mortality above Western peers. Cancer survival below Nordic countries. Heart attack mortality higher than Sweden. Elective waiting lists of 7.3–7.4 million. Clinical negligence costs of £3.1 billion per year against a £60 billion total liability. Agency spend peaked at £3.5 billion. And an operational productivity crisis: 38% of theatre lists underutilised, £400 million in wasted theatre time annually, a waiting list that barely moved despite a 20% workforce increase.
The statistical correlations between staffing and outcomes are not speculative. A 1% increase in nurse staffing density reduces acute cardiac and stroke mortality by 0.65–0.80%. An extra RN shift reduces ward-level mortality odds by 9.6%. Senior experienced RNs have more than twice the mortality-reducing impact of junior nurses. Section 9 traces the complete causal chain: pay suppression → attrition → vacancies → agency reliance → depleted experienced workforce → worse clinical outcomes. The NHS Pay Review Body itself has concluded that investing in pay would improve patient outcomes.
The question is no longer whether we can afford to invest properly in NHS staffing. The operational data asks a more pointed question: can we afford not to?
Key Sources & Verified References
- OECD / European Commission (2024). Health at a Glance: Europe 2024. doi.org/10.1787/b3704e14-en
- OECD (2025). Health at a Glance 2025. doi.org/10.1787/8f9e3f98-en
- Nuffield Trust (2024). Still waiting: Is it just England that still has a backlog problem? nuffieldtrust.org.uk
- Nuffield Trust (2024). Mortality rates. nuffieldtrust.org.uk/resource/mortality-rates
- Propper, C. et al. (2023). BMJ Quality & Safety. PMC10176371
- Dall’Ora, C. et al. (2024). JAMA Network Open. PMC11333978
- Dall’Ora, C. et al. (2023). Human Resources for Health. PMC10116759
- Labbé, V. et al. (2018). ScienceDirect
- NHS Resolution (2025). resolution.nhs.uk
- National Audit Office (2025). nao.org.uk
- House of Commons Public Accounts Committee (2025). publications.parliament.uk
- House of Commons Library (2025). commonslibrary.parliament.uk
- EUROCARE-6 / OECD (2024–25). OECD.org (PDF)
- Coleman, M. et al. (2011). PMID 21183212
- Jernberg, T. et al. (2015). PMC4528190
- OECD (2024). oecd.org
- King’s Fund (2025). kingsfund.org.uk
- Pandit, J.J. et al. (2023). PMC10308435
- Institute for Fiscal Studies (2025). ifs.org.uk
- NHS England (2025). england.nhs.uk
- ONS (2025). ons.gov.uk
- Agyemang, C. et al. / UK-REACH (2025). PMC12541634
- NHS Employers (2023). nhsemployers.org
- Khamisa, N. et al. (2020). PMC7375434
- NHS Pay Review Body (2023). assets.publishing.service.gov.uk (PDF)
No comments:
Post a Comment